Dali Pharmaceutical Co Ltd Class A 603963
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 5.20
- Day Range
- CNY 4.94–5.21
- 52-Week Range
- CNY 4.85–15.97
- Bid/Ask
- CNY 4.97 / CNY 4.98
- Market Cap
- CNY 1.09 Bil
- Volume/Avg
- 13.8 Mil / 13.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 18.18
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 272
- Website
- http://www.daliyaoye.cn
Comparables
Valuation
|
Metric
|
603963
|
600422
|
002873
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 47.51 | 42.54 |
Price/Book Value | 3.14 | 3.16 | 2.60 |
Price/Sales | 18.18 | 2.21 | 3.03 |
Price/Cash Flow | — | 20.84 | 28.35 |
Price/Earnings
603963
600422
002873
Financial Strength
|
Metric
|
603963
|
600422
|
002873
|
|---|---|---|---|
Quick Ratio | 3.10 | 1.40 | 0.78 |
Current Ratio | 3.98 | 1.93 | 1.15 |
Interest Coverage | −13.31 | 25.92 | 8.75 |
Quick Ratio
603963
600422
002873
Profitability
|
Metric
|
603963
|
600422
|
002873
|
|---|---|---|---|
Return on Assets (Normalized) | −6.09% | 3.60% | 3.86% |
Return on Equity (Normalized) | −7.42% | 6.51% | 6.53% |
Return on Invested Capital (Normalized) | −6.63% | 5.54% | 4.87% |
Return on Assets
603963
600422
002873
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Thcvbnyx | Vrrxpl | $79.9 Bil | |
ZTS
| Zoetis Inc Class A | Jnkcxggnb | Thns | $79.3 Bil | |
HLN
| Haleon PLC ADR | Htymbglh | Vydy | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Cfhftkq | Cbqmj | $18.9 Bil | |
VTRS
| Viatris Inc | Dpmnjfp | Mnf | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kngstjvr | Gcfxx | $11.7 Bil | |
CTLT
| Catalent Inc | Tpmldbrs | Zqwqgf | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Grwtbym | Ntk | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Wyzszfx | Xwyf | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ygkyhtvwy | Tswhfk | $3.2 Bil |